JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265182

Human RPL36A knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

RPL36A KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and Insertion of the selection cassette in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
3 Images
Sanger Sequencing - Human RPL36A knockout HeLa cell line (AB265182)
  • Sanger seq

Unknown

Sanger Sequencing - Human RPL36A knockout HeLa cell line (AB265182)

Allele-2 : Insertion of the selection cassette in exon 1.

Sanger Sequencing - Human RPL36A knockout HeLa cell line (AB265182)
  • Sanger seq

Unknown

Sanger Sequencing - Human RPL36A knockout HeLa cell line (AB265182)

Allele-1 : 1 bp insertion in exon 1.

Sanger Sequencing - Human RPL36A knockout HeLa cell line (AB265182)
  • Sanger seq

Unknown

Sanger Sequencing - Human RPL36A knockout HeLa cell line (AB265182)

Allele-3 : Insertion of the selection cassette in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and Insertion of the selection cassette in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265182-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265182 Human RPL36A knockout HeLa cell line", "number":"AB265182-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265182-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265182-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265182-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265182 Human RPL36A knockout HeLa cell line", "number":"AB265182-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265182-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265182 Human RPL36A knockout HeLa cell line", "number":"AB265182-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265182-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265182 Human RPL36A knockout HeLa cell line", "number":"AB265182-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
RPL36A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RPL36A also known as Ribosomal Protein L36-A or L36A is a component of the 60S ribosomal subunit. This protein has a mass of approximately 12 kDa and is widely expressed in various tissues mainly reflecting its fundamental role in cellular processes. As an essential part of the ribosome RPL36A helps facilitate the translation of messenger RNA into proteins contributing to the protein synthesis machinery which is essential for cell function and proliferation.
Biological function summary

RPL36A is involved in the ribosome's structural integrity and function. It assumes an important role within the ribosomal large subunit by engaging in ribosome assembly and stability. As a part of the ribosomal complex RPL36A contributes to the decoding and translocation phases during protein biosynthesis. Its integration within this complex highlights its significance in cellular metabolism and growth.

Pathways

RPL36A plays an integral part in the translation pathway specifically in the process of translation initiation and elongation. It is actively involved in the assembly of the pre-initiation complex and the elongation cycle. Additionally RPL36A interacts within the mTOR signaling pathway which regulates cell growth and metabolism in response to nutrients growth factors and other stimuli. Through this pathway its relationship with proteins like S6 kinase is noteworthy as they collectively influence protein synthesis rate and cell growth.

Alterations in RPL36A can potentially relate to cancer and Diamond-Blackfan anemia (DBA). Changes in the expression levels or mutations of RPL36A have been implicated in the development of certain cancers where enhanced ribosomal biogenesis supports tumor growth. In DBA a disorder characterized by failure in red blood cell production mutations in ribosomal proteins like RPL36A disrupt ribosome function leading to hematological abnormalities. Interactions with other ribosomal proteins such as RPS19 further illustrate its involvement in the pathogenesis of ribosomopathies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com